Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ISRCTN |
Last refreshed on:
|
17 October 2016 |
Main ID: |
ISRCTN15655996 |
Date of registration:
|
12/06/2015 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Diverting ileostomy after low anterior resection
|
Scientific title:
|
Diverting ileostomy versus no diversion after low anterior resection for rectal cancer: a prospective randomised multicenter trial |
Date of first enrolment:
|
01/01/2004 |
Target sample size:
|
210 |
Recruitment status: |
Completed |
URL:
|
http://isrctn.com/ISRCTN15655996 |
Study type:
|
Interventional |
Study design:
|
Two-arm randomised open-label multicentre study (Treatment)
|
Phase:
|
|
|
Countries of recruitment
|
Austria
| | | | | | | |
Contacts
|
Name:
|
|
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
|
|
Name:
|
Jörg
Tschmelitsch |
Address:
|
Department of Surgery
Brothers of Mercy Hospital St. Veit
Spitalgasse 26
9300 St. Veit/Glan
9300
St. Veit/Glan
Austria |
Telephone:
|
+43 (0)421 249 9475 |
Email:
|
joerg.tschmelitsch@bbstveit.at |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1. Patients aged 19 to 85 years with biopsy-proven and operable rectal cancer 2. Patients with or without preoperative radio-chemotherapy 3. Patients with a distal border of the tumour within 16 cm from the anal verge as demonstrated by rigid rectoscopy 4. Patients with a WHO performance status = 2
Exclusion criteria: 1. Patients with previous rectal surgery 2. Emergency cases 3. Planned laparoscopic resections 4. Patients suffering from metastatic disease or synchronous colon cancer
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Histologically verified and operable rectal cancer Cancer
|
Intervention(s)
|
Patients were stratified by gender, anastomotic height and preoperative radio-chemotherapy to be operated either by rectal resection and colo-anal/rectal anastomosis with a diverting ileostomy (group A) or rectal resection and colo-anal/rectal anastomosis without protective ileostomy (group B). Patients in both groups with low anastomoses (< 8 cm) were planned to receive a colonic J-pouch reconstruction.
|
Primary Outcome(s)
|
The primary efficacy endpoint of the present study was the overall anastomotic leakage rate as defined by one of the following: 1. Radiologic leak: radiologic evidence of a leak in a Gastrografin enema and/or CT scan without clinical signs of anastomotic leakage 2. Clinical leak: radiologic evidence of a leak in a Gastrografin enema and/or CT scan and/or sigmoidoscopy with one or more of the following clinical signs: elevated temperature (> 380C), leucocytosis, peritonitis, putrid or faecal discharge over the drainage or fistulas (recto-vaginal)
|
Secondary Outcome(s)
|
1. Surgical complications related to primary surgery, to the stoma before closure and to secondary surgery for stoma closure 2. Postoperative mortality defined as death on account of any cause during the hospital stay due to the primary operation or stoma closure 3. The length of hospital stay in days for the primary operation and stoma closure
|
Source(s) of Monetary Support
|
Brothers of Mercy Hospital (Austria)
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|